Stock SWAV SHOCKWAVE MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
330 USD +0.31% Intraday chart for Shockwave Medical, Inc. +0.30% +73.17%
Apr. 11 Health Care Slips on Risk Bias -- Health Care Roundup DJ
Apr. 09 CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,350 3,553 6,296 7,431 7,031 12,378 - -
Enterprise Value (EV) 1 1,168 3,368 6,112 7,151 6,772 11,868 11,561 11,175
P/E ratio -20.5 x -52.1 x -686 x 36.1 x 49.5 x 68.3 x 53.7 x 44.8 x
Yield - - - - - - - -
Capitalization / Revenue 31.4 x 52.4 x 26.5 x 15.2 x 9.63 x 13.4 x 10.9 x 9.04 x
EV / Revenue 27.2 x 49.7 x 25.8 x 14.6 x 9.27 x 12.9 x 10.2 x 8.16 x
EV / EBITDA -24.9 x -63 x 204 x 41.1 x 27.9 x 45.2 x 33 x 26.2 x
EV / FCF - - 2,353 x - 40.9 x 52.5 x 53.8 x 35.1 x
FCF Yield - - 0.04% - 2.44% 1.91% 1.86% 2.85%
Price to Book 7.17 x 15.9 x 25.9 x 14.6 x 10.5 x 13.1 x 9.68 x 7.62 x
Nbr of stocks (in thousands) 30,738 34,260 35,304 36,142 36,897 37,508 - -
Reference price 2 43.92 103.7 178.3 205.6 190.6 330.0 330.0 330.0
Announcement Date 2/13/20 2/17/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 42.93 67.79 237.1 489.7 730.2 920.9 1,133 1,369
EBITDA 1 -46.86 -53.45 29.96 173.9 242.7 262.8 350.3 427
EBIT 1 -51.84 -65.66 -0.871 124.1 159.1 212.2 291.4 380.3
Operating Margin -120.76% -96.86% -0.37% 25.35% 21.79% 23.05% 25.73% 27.77%
Earnings before Tax (EBT) 1 -51.05 -65.62 -8.835 120.8 174.3 234.3 308.3 386.9
Net income 1 -51.11 -65.7 -9.136 216 147.3 187.2 243.4 302
Net margin -119.06% -96.92% -3.85% 44.1% 20.17% 20.32% 21.49% 22.05%
EPS 2 -2.140 -1.990 -0.2600 5.700 3.850 4.833 6.142 7.362
Free Cash Flow 1 - - 2.597 - 165.5 226.1 215 318
FCF margin - - 1.1% - 22.66% 24.55% 18.98% 23.22%
FCF Conversion (EBITDA) - - 8.67% - 68.18% 86.04% 61.38% 74.47%
FCF Conversion (Net income) - - - - 112.34% 120.81% 88.33% 105.31%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/13/20 2/17/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 65.16 84.18 93.63 120.7 131.3 144 161.1 180.2 186 203 207.6 226.6 232 253.9 255.4
EBITDA 1 3.901 23.08 25.84 41.69 49.75 56.6 57.49 50.91 65.04 68.17 53.86 65.19 69.77 79.82 76.5
EBIT 1 2.813 13.98 15.37 29.58 36.76 42.42 39.81 32.37 43.62 43.28 39.36 50.66 53.78 64.41 58.38
Operating Margin 4.32% 16.61% 16.42% 24.49% 27.99% 29.46% 24.72% 17.97% 23.45% 21.32% 18.96% 22.35% 23.18% 25.37% 22.86%
Earnings before Tax (EBT) 1 2.026 13.05 14.72 26.34 35.12 44.65 40.74 33 45.08 55.46 48.13 58.44 60.64 71.73 65.33
Net income 1 1.948 12.94 14.52 25.56 35 140.9 39.12 28.86 34.99 44.3 37.39 46.29 48.95 57.56 54.56
Net margin 2.99% 15.37% 15.51% 21.17% 26.65% 97.84% 24.29% 16.02% 18.81% 21.83% 18.01% 20.42% 21.1% 22.67% 21.37%
EPS 2 0.0500 0.3400 0.3900 0.6800 0.9200 3.710 1.030 0.7600 0.9200 1.160 0.9714 1.198 1.261 1.477 1.414
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/8/21 2/17/22 5/9/22 8/8/22 11/7/22 2/16/23 5/8/23 8/7/23 11/6/23 2/15/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 182 186 184 280 259 509 817 1,202
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - 2.6 - 165 226 215 318
ROE (net income / shareholders' equity) -146% -31.4% -3.91% 57.4% 25% 26.2% 21.4% 19.2%
ROA (Net income/ Total Assets) - - - 43.6% 13.3% 9.17% 10.1% 10.5%
Assets 1 - - - 495.9 1,106 2,040 2,406 2,883
Book Value Per Share 2 6.130 6.530 6.890 14.10 18.10 25.20 34.10 43.30
Cash Flow per Share 2 -2.010 -2.150 - 3.110 5.130 5.480 1.120 6.450
Capex 1 - - - 25.1 30.6 38.4 45.3 47.5
Capex / Sales - - - 5.13% 4.19% 4.17% 4% 3.47%
Announcement Date 2/13/20 2/17/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shockwave Medical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
330 USD
Average target price
294.3 USD
Spread / Average Target
-10.83%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.17% 12.38B
PENUMBRA, INC. Stock Penumbra, Inc.
-18.74% 7.92B
MASIMO CORPORATION Stock Masimo Corporation
+16.15% 7.2B
GETINGE AB Stock Getinge AB
+4.81% 5.84B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+5.99% 5.07B
APT MEDICAL INC. Stock APT Medical Inc.
+27.07% 4.53B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.67% 3.88B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-40.82% 2.23B
SKAN GROUP AG Stock SKAN Group AG
+1.49% 2.02B
SHENZHEN YHLO BIOTECH CO., LTD. Stock Shenzhen YHLO Biotech Co., Ltd.
+5.07% 1.88B
Medical Equipment
  1. Stock Market
  2. Equities
  3. SWAV Stock
  4. Financials Shockwave Medical, Inc.